Results per Page:
HLA haplotype allelic variations can influence leukemia recurrence after blood stem cell transplantation
From the Petersdorf Group, Translational Science and Therapeutics Division
Dr. Fred Appelbaum receives Lifetime Achievement award
Medical pioneer and longtime Fred Hutch leader honored by American Society for Transplantation and Cellular Therapy
Leading the way: BLEAT, a novel HLA-B Leader Assessment Tool
From the Petersdorf Lab, Clinical Research Division
HLA-B leader sequences influence graft-versus-host-disease
From the Petersdorf laboratory, Clinical Research Division
Harnessing the power of genetics to improve transplant safety
From the Petersdorf Group, Clinical Research Division
The legacy of a pioneering transplant immunologist
‘So much to be learned’: Dr. John Hansen reflects on the lives he’s saved and the answers still to come
New partnership seeks to increase access to lifesaving stem-cell transplants
Celebrating faculty and staff achievements
Good News at Fred Hutch
Celebrating faculty and staff achievements
Finding a better (mis)match
New way to pair blood stem cell donors with recipients promises to lower risk of potentially devastating transplant side effect
Good News at Fred Hutch
<p>Dr. Amanda Paulovich wins proteomic sciences award; Dr. David Coffey receives ASH research training award; endowed chair named in honor of the late Dr. Stephen Petersdorf</p>
Researchers uncover new genetic clues to why most bone marrow transplant patients develop graft-versus-host disease
Discovery will lead to new screening protocol to better match patients & donors
Discovery may reduce GVHD risk in bone marrow transplant patients
Team of scientists led by the Fred Hutchinson Cancer Research Center’s Dr. Effie Petersdorf find previously undetected genetic differences that could better match transplant patients and donors to avoid graft-vs.-host disease.
From Criminology to Seeking a Cure for Cancer — Today's DNA Analytical Tools Make Possible What Was Once Unthinkable
Fred Hutchinson Cancer Research Center finds that in some cases a mismatched donor may work for leukemia patients — expanding the donor pool and increasing opportunity for people seeking lifesaving treatment